Author Archives: Aliza Glasner

04.24.14

A nutritionist named Coca-Cola

By

This week, the Supreme Court heard arguments in a case brought by POM Wonderful  gainst Coca-Cola, alleging fraudulent and deceptive advertising of Coca-Cola’s Pomegranate-Blueberry juice. The legal question centered on whether a private party can bring a lawsuit for misleading advertising if a label is compliant with regulations established by a federal agency, here the […]

Categories:

Tags:

03.13.14

Is obesity the ticket to fighting antibiotic resistance?

By

Research points to the possibility that taking antibiotics could lead to weight gain. Could this reality be the necessary catalyst to change the way we use antibiotics in general?Antibiotic overuse is a public health crisis. For decades, scientists have supported changing antibiotic prescribing practices in response to the alarming consequences of their overuse – most […]

Categories:

Tags:

02.12.14

Do prescription drugs need a message?

By

The recent controversy surrounding a relatively new blood thinner called Pradaxa (dabigatran) centers not on the drug itself, but on the safety of the drug’s message. Brought to market as a superior product to the long-standing market leader, Coumadin (warfarin), Pradaxa is touted for its ability to treat atrial fibrillation without the inconvenience of frequent […]

Categories:

Tags:

09.17.13

Public Health Math: Does “less bad” = “good”? A look at the increasing popularity of e-cigarettes

By

The field of public health is premised on epidemiological number games. While eradicating disease may be the paragon of the field, in practice, public health leaders apply a more rational lens focused on achieving the best health outcomes for the majority.  Tackling the health issues associated with tobacco products presents a ripe example of this […]

Categories:

Tags:

07.30.13

Sugary Beverages Have Their Day in Court

By

          Yesterday, the Appellate Division of the New York Supreme Court (“the Court”) affirmed the State’s Supreme Court decision finding that the New York City Board of Health and Mental Hygiene’s  (DOHMH) Sugary Drinks Portion Cap Rule, or the “Soda Ban” was unconstitutional. Accordingly, the Appellate Court concluded that “in promulgating […]

Categories:

Tags:

07.22.13

Will FDA Turn the Tide on Industry-wide Medical Product Development?

By

The advent of big data has forced a sea change throughout the scientific research enterprise, shaking the industry’s fundamental attitude towards the data themselves. Data is now understood as the currency of research. Consequently, industry is warming to the new reality that legal norms once considered to drive business – confidential commercial information, trade secrets […]

Categories:

Tags:

04.30.13

The Power of Sharing: Rethinking the Future of Intellectual Property and Biomedical Research

By

Recently, the U.S. Supreme Court heard oral arguments in Association for Molecular Pathology v. Myriad Genetics, Case No. 11-725, on the eligibility of patenting the BRCA1 and BRCA2 genes, which identify hereditary breast and ovarian cancers. The Court granted certiorari to hear this case after a split developed among the United States circuit court of […]

Categories:

Tags:

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.